Elke S. Hoendermis

Groningen, GR, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 68 publications

MRI-derived IVIM-modelled diffusion-weighted imaging does not predict clinical outcomes in fontan-associated liver disease: to monitor or not to monitor the liver?

MRI-derived IVIM-modelled diffusion-weighted imaging does not predict clinical outcomes in fontan-associated liver disease: to monitor or not to monitor the liver?

Journal: Frontiers in pediatrics

Published: February 23, 2026

Heart Failure Duration, Cardiac Remodeling, Dysfunction, and Hemodynamic Severity in HFpEF and HFmrEF: Insights From REDUCE LAP-HF II.

Heart Failure Duration, Cardiac Remodeling, Dysfunction, and Hemodynamic Severity in HFpEF and HFmrEF: Insights From REDUCE LAP-HF II.

Journal: JACC. Heart failure

Published: February 16, 2026

Pulmonary Restriction in Patients With a Fontan Circulation: Determinants, Deterioration Over Time, and Clinical Implications.

Pulmonary Restriction in Patients With a Fontan Circulation: Determinants, Deterioration Over Time, and Clinical Implications.

Journal: Journal of cardiopulmonary rehabilitation and prevention

Published: February 02, 2026

Estimating the Placebo Effect on Patient-Reported Outcomes in Sham-controlled Device Trials: Insights from REDUCE LAP-HF II.

Estimating the Placebo Effect on Patient-Reported Outcomes in Sham-controlled Device Trials: Insights from REDUCE LAP-HF II.

Journal: Circulation. Population health and outcomes

Published: January 19, 2026

Corrigendum to "Long-term safety and outcomes after atrial shunting for heart failure with preserved or mildly reduced ejection fraction: 5-year and 3-year follow-up in the REDUCE LAP-HF I and II trials" [American Heart Journal (278)2024 Page Number:106-116].

Corrigendum to "Long-term safety and outcomes after atrial shunting for heart failure with preserved or mildly reduced ejection fraction: 5-year and 3-year follow-up in the REDUCE LAP-HF I and II trials" [American Heart Journal (278)2024 Page Number:106-116].

Journal: American heart journal

Published: December 19, 2025

Reconstruction of an Unguarded Tricuspid Orifice Using a Simplified Sliding Plasty Technique.

Reconstruction of an Unguarded Tricuspid Orifice Using a Simplified Sliding Plasty Technique.

Journal: Interdisciplinary cardiovascular and thoracic surgery

Published: December 09, 2025

Stroke and transient ischemic attack recurrence after PFO closure in patients with cryptogenic embolism.

Stroke and transient ischemic attack recurrence after PFO closure in patients with cryptogenic embolism.

Journal: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Published: October 14, 2025

Initial experience with combined heart-liver transplantation in the Netherlands: Exploring the boundaries of isolated and combined transplantation.

Initial experience with combined heart-liver transplantation in the Netherlands: Exploring the boundaries of isolated and combined transplantation.

Journal: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Published: June 24, 2025

Hemodynamic profiling of patients with a Fontan circulation using pulmonary pressure/flow relations during dobutamine stress and pulmonary vasodilation testing.

Hemodynamic profiling of patients with a Fontan circulation using pulmonary pressure/flow relations during dobutamine stress and pulmonary vasodilation testing.

Journal: American journal of physiology. Heart and circulatory physiology

Published: June 12, 2025

Epicardial Adipose Tissue, Functional Status, and Invasive Hemodynamics in Heart Failure With Preserved Ejection Fraction.

Epicardial Adipose Tissue, Functional Status, and Invasive Hemodynamics in Heart Failure With Preserved Ejection Fraction.

Journal: JACC. Advances

Published: May 15, 2025

Carbohydrate antigen-125 (CA125): a marker of right ventricular dysfunction and poor prognosis in heart failure with preserved ejection fraction.

Carbohydrate antigen-125 (CA125): a marker of right ventricular dysfunction and poor prognosis in heart failure with preserved ejection fraction.

Journal: International journal of cardiology. Heart & vasculature

Published: April 16, 2025

Heart failure in patients with a systemic right ventricle: A multicentre study with long-term follow-up.

Heart failure in patients with a systemic right ventricle: A multicentre study with long-term follow-up.

Journal: European journal of heart failure

Published: October 28, 2024

Showing 1-12 of 68

Last Updated: 09/26/2026